January 20, 2010

The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...

January 19, 2010

Alcon has seen Novartis’ acquisition offer, and it is not impressed....

January 19, 2010

Two drug companies are in a race to buy a German generic drug maker, according...

January 13, 2010

The chairman of the Federal Trade Commission and several members of Congress are calling for...

January 13, 2010

Moody’s Investors Service announced Wednesday that it had upgraded the ratings of generic drug maker...

January 12, 2010

Four drug companies have received warnings from the Food and Drug Administration in the last...

January 12, 2010

Teva hopes to garner revenues of $31 billion and net income of $6.8 billion by...

January 11, 2010

Biogen Idec hopes to win approval for a multiple sclerosis drug in Canada and the...

January 10, 2010

Sanofi-Aventis is the latest pharma powerhouse to make the move toward over-the-counter medicine with its...

January 7, 2010

A biopharmaceutical company announced the resignation of one of its executives....

January 7, 2010

Watson Labs, a subsidiary of specialty pharmaceutical company Watson Pharmaceuticals, has filed an abbreviated new...

January 6, 2010

A privately held drug development company announced the closure of its acquisition by Eisai for...

January 6, 2010

GlaxoSmithKline will be underwriting a weight-loss/eating documentary in partnership with the Creative Coalition, an advocacy...

January 5, 2010

The Food and Drug Administration approved 26 drugs in 2009, compared with 25 approvals in 2008....

January 4, 2010

A maker of generic injectable drugs is involved in a patent infringement suit over a...

January 4, 2010

An India drug maker is in generic drug supply talks with two companies, according to...

January 3, 2010

The Food and Drug Administration has requested additional information and recommended additional clinical studies be...

January 3, 2010

Novartis is looking to purchase the remaining shares in an eye care company....

January 3, 2010

A generic drug maker has announced the availability of a treatment of the signs and...

December 20, 2009

This is further substantiation that the business of over-the-counter medicines, particularly those sold in the...

March 12, 2009

The last few weeks have seen a lot of acquisition activity among large pharmaceutical companies....

January 11, 2009

Par Pharmaceutical Cos. had total sales of $291.9 million and $26.3 million in profit for...

November 10, 2008

The situation is like having plans to bake a loaf of bread for dinner, but discovering at 5 p.m. that the flour is running low, and there is little time to go to the supermarket to buy more. Generic drug makers depend on a steady supply of expiring patents coming from large pharmaceutical companies for their business. In recent years, a whole slew of blockbuster drugs have come off patent, allowing generic drug makers to lap up the drug compounds. Over the next several years, however, the supply of expiring patents will begin to run dry. Between this year and 2016, $131 billion worth of drugs will come off patent, followed by a long decline often called the patent cliff. Facing this precipice, generic drug companies will have to adapt as the market becomes increasingly commoditized.

September 19, 2007

Hi-Tech Pharmaceuticals has received final approval from the Food and Drug Administration for its application...